Estimation of the malignant potential of gastrointestinal stromal tumors: the value of contrast-enhanced coded phase-inversion harmonics US

[1]  M. Kudo,et al.  Dynamic imaging of pancreatic diseases by contrast enhanced coded phase inversion harmonic ultrasonography , 2004, Gut.

[2]  P. Morel,et al.  Are there any prognostic factors for small intestinal stromal tumors? , 2004, American journal of surgery.

[3]  E. Lerma,et al.  Stromal tumours of the gastrointestinal tract: a clinicopathological and ploidy analysis of 33 cases , 2004, Virchows Archiv.

[4]  R. Schneider-Stock,et al.  KIT 1530ins6 mutation defines a subset of predominantly malignant gastrointestinal stromal tumors of intestinal origin. , 2003, Human pathology.

[5]  Y. Matsuzawa,et al.  Endoscopic ultrasonography-guided fine needle aspiration biopsy in follow-up patients with gastrointestinal stromal tumours , 2003, European journal of gastroenterology & hepatology.

[6]  S. Hirota,et al.  Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumors. , 2003, Gastroenterology.

[7]  M. Kudo,et al.  Transcatheter arterial chemoembolization of hepatocellular carcinoma: usefulness of coded phase-inversion harmonic sonography. , 2003, AJR. American journal of roentgenology.

[8]  Samuel Singer,et al.  PDGFRA Activating Mutations in Gastrointestinal Stromal Tumors , 2003, Science.

[9]  D. C. Brewster,et al.  Prognostic indicators for gastrointestinal stromal tumours , 2003 .

[10]  J. Fletcher,et al.  Prognostic value of KIT mutation type, mitotic activity, and histologic subtype in gastrointestinal stromal tumors. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  L. Sobin,et al.  Diagnosis of gastrointestinal stromal tumors: A consensus approach. , 2002, Human pathology.

[12]  W. El-Rifai,et al.  Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review. , 2002, Human pathology.

[13]  M. Kudo.  Imaging Blood Flow Characteristics of Hepatocellular Carcinoma , 2002, Oncology.

[14]  N. Jonjić,et al.  Prognostic factors of gastrointestinal stromal tumors. , 2002, Anticancer research.

[15]  M. Kudo,et al.  Evaluation of posttreatment response of hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: comparison with dynamic CT. , 2001, Radiology.

[16]  M. Kudo,et al.  Sonographic diagnosis of pancreatic islet cell tumor: Value of intermittent harmonic imaging , 2001, Journal of clinical ultrasound : JCU.

[17]  D. Faigel,et al.  Fine‐needle aspiration biopsy diagnosis of gastrointestinal stromal tumors using morphology, immunocytochemistry, and mutational analysis of c‐kit , 2001, Cancer.

[18]  S. Hirota,et al.  Biological and clinical review of stromal tumors in the gastrointestinal tract. , 2000, Histology and histopathology.

[19]  R. Cheney,et al.  Gastrointestinal Stromal Tumors: Current Diagnosis, Biologic Behavior, and Management , 2000, Annals of Surgical Oncology.

[20]  E. de Álava,et al.  Predicting Metastatic Risk of Gastrointestinal Stromal Tumors: Role of Cell Proliferation and Cell Cycle Regulatory Proteins , 2000, International journal of surgical pathology.

[21]  J. Lasota,et al.  Gastrointestinal stromal tumors: recent advances in understanding of their biology. , 1999, Human pathology.

[22]  S. Hirota,et al.  Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors. , 1999, Cancer research.

[23]  Edvardsson,et al.  Expression of c‐kit (CD117) and Ki67 provides information about the possible cell of origin and clinical course of gastrointestinal stromal tumours , 1999, Histopathology.

[24]  A. Roche.  Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma , 1999 .

[25]  J. Lasota,et al.  Mutations in exon 11 of c-Kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas. , 1999, The American journal of pathology.

[26]  L. Sobin,et al.  KIT mutation portends poor prognosis in gastrointestinal stromal/smooth muscle tumors. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[27]  F. Galibert,et al.  Sequence analysis of two genomic regions containing the KIT and the FMS receptor tyrosine kinase genes. , 1997, Genomics.

[28]  K. Franssila,et al.  Molecular diagnosis of mantle cell lymphoma in paraffin-embedded tissue. , 1996, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[29]  S. Sheen-Chen,et al.  Smooth muscle tumors of the gastrointestinal tract: analysis of prognostic factors. , 1996, Surgery.

[30]  M. Miettinen,et al.  Gastrointestinal stromal tumors--value of CD34 antigen in their identification and separation from true leiomyomas and schwannomas. , 1995, The American journal of surgical pathology.

[31]  D. Franquemont.  Differentiation and risk assessment of gastrointestinal stromal tumors. , 1995, American journal of clinical pathology.

[32]  S. Haque,et al.  Stromal neoplasms of the rectum and anal canal. , 1992, Human pathology.

[33]  E. Atkinson,et al.  Prognostic factors influencing survival in gastrointestinal leiomyosarcomas. Implications for surgical management and staging. , 1992, Annals of surgery.

[34]  N. Kiviat,et al.  PCR amplification from paraffin-embedded tissues. Effects of fixative and fixation time. , 1991, American journal of clinical pathology.

[35]  J. Folkman,et al.  Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. , 1991, The New England journal of medicine.

[36]  G. Pinkus,et al.  Are keratin proteins a better tumor marker than epithelial membrane antigen? A comparative immunohistochemical study of various paraffin-embedded neoplasms using monoclonal and polyclonal antibodies. , 1986, American journal of clinical pathology.